{
    "initial_questions": "Here are the multiple-choice questions for each Bloom's Taxonomy level:\n\n**Knowledge**\n\n1) What is the approximate number of cells in the human body?\n    - A: 10 trillion\n    - B: 30 trillion\n    - C: 50 trillion\n    - D: 100 trillion\n[Correct answer]: B\n\n2) What are the four chemical letters that make up DNA?\n    - A: A, C, T, and U\n    - B: A, C, T, and G\n    - C: A, G, C, and D\n    - D: T, A, G, and C\n[Correct answer]: B\n\n**Comprehension**\n\n1) What is the result of the immune system's inability to recognize and destroy rogue cells?\n    - A: Cancer\n    - B: Genetic variation\n    - C: Evolution\n    - D: Immunotherapy\n[Correct answer]: A\n\n2) What is CAR T-cell therapy, and how does it work?\n    - A: It's a type of chemotherapy that uses a patient's own T-cells to fight cancer.\n    - B: It's a type of immunotherapy that uses a patient's own T-cells to fight cancer.\n    - C: It's a type of radiation therapy that uses a patient's own T-cells to fight cancer.\n    - D: It's a type of surgery that uses a patient's own T-cells to fight cancer.\n[Correct answer]: B\n\n**Application**\n\n1) What is a potential use of CAR T-cell therapy in treating blood cancers?\n    - A: Treating acute myeloid leukemia\n    - B: Treating acute lymphoblastic leukemia\n    - C: Treating chronic lymphocytic leukemia\n    - D: Treating chronic myeloid leukemia\n[Correct answer]: B\n\n2) How can understanding the immune system help us develop new treatments for diseases like cancer?\n    - A: By identifying new targets for chemotherapy\n    - B: By developing new surgical techniques\n    - C: By designing new genetic code to reprogram T-cells\n    - D: By improving our understanding of how the immune system works\n[Correct answer]: D\n\n**Analysis**\n\n1) What is the relationship between genetic variation and evolution in understanding how cancer develops?\n    - A: Genetic variation leads to evolution, which leads to cancer.\n    - B: Evolution leads to genetic variation, which leads to cancer.\n    - C: Genetic variation and evolution are unrelated to cancer development.\n    - D: The relationship between genetic variation and evolution is crucial in understanding how cancer develops.\n[Correct answer]: D\n\n2) What is the key challenge in cancer treatment related to the immune system's ability to recognize internal cancer cells?\n    - A: The immune system is too weak to recognize internal cancer cells.\n    - B: The immune system is too strong and recognizes internal cancer cells as healthy cells.\n    - C: The immune system has a hard time recognizing internal cancer cells because they have similar antigens to healthy cells.\n    - D: The immune system is unable to recognize internal cancer cells due to a lack of genetic variation.\n[Correct answer]: C\n\n**Synthesis**\n\n1) What is a potential outcome of combining genetic engineering and immunotherapy in cancer treatment?\n    - A: The development of new and innovative treatments for cancer\n    - B: The improvement of existing treatments for cancer\n    - C: The reduction of side effects associated with cancer treatment\n    - D: The increase in cost of cancer treatment\n[Correct answer]: A\n\n2) How can CAR T-cell therapy be combined with other treatments to improve patient outcomes?\n    - A: By using it in conjunction with chemotherapy\n    - B: By using it in conjunction with radiation therapy\n    - C: By using it in conjunction with surgery\n    - D: By using it as a standalone treatment\n[Correct answer]: A\n\n**Evaluation**\n\n1) How can the effectiveness of CAR T-cell therapy be evaluated in treating certain types of cancer?\n    - A: By looking at patient survival rates and remission rates\n    - B: By looking at the cost of treatment\n    - C: By looking at the accessibility of treatment\n    - D: By looking at the potential risks and benefits of treatment\n[Correct answer]: A\n\n2) What is a potential consideration when evaluating the ethics of genetic engineering in cancer treatment?\n    - A: The potential risks and benefits of treatment\n    - B: The cost and accessibility of treatment\n    - C: The effectiveness of treatment in improving patient outcomes\n    - D: The potential impact on healthcare systems\n[Correct answer]: A"
}